Peru’s InRetail Pharma names banks, sets roadshow for proposed medium-term benchmark notes

By Rebecca Melvin

New York, April 19 – InRetail Pharma SA has selected banks and scheduled fixed-income investor meetings for a proposed benchmark-sized offering of medium-term notes (Ba2//BB+), according to a market source on Thursday.

Credit Suisse, JPMorgan and Citigroup are arranging the roadshow meetings for the Rule 144A and Regulation S deal.

Meetings begin on Thursday and wrap up next Wednesday, with three teams making stops in Santiago, Lima, Los Angeles, Boston, New York, London, Geneva and Zurich.

The company is refinancing a bridge loan associated with its acquisition of Quicorp SA in January.

InRetail Pharma is a pharmacy operator based in Lima, Peru.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.